Navigation Links
Endo Pharmaceuticals Reports First Quarter 2009 Financial Results
Date:4/29/2009

$268,478 Total Generics $42,393 $21,793 Total Net Sales $335,300 $290,271 *Other Brands includes Indevus results beginning on February 23, 2009.

The following table presents condensed consolidated cash flow data for the three months ended March 31, 2009 and March 31, 2008:

                         Endo Pharmaceuticals Holdings Inc.
                    Condensed Consolidated Cash Flow Data (unaudited)
                                   (in thousands)


                                                     Three Months Ended
                                                           March 31,

                                                       2009         2008

    Net cash provided by operating activities        $35,031      $75,453

    Net cash (used in) provided by investing
     activities                                     (423,555)     125,385

    Net cash provided by (used in) financing
     activities                                        6,988         (623)

    Net (decrease) increase in cash and cash
     equivalents                                   $(381,536)    $200,215

    Cash and cash equivalents, beginning of
     period                                         $775,693     $350,325

    Cash and cash equivalents, end of period        $394,157     $550,540




'/>"/>
SOURCE Endo Pharmaceuticals
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine news :

1. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
2. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
3. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
4. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
5. Vista Partners Updates Coverage on Tapestry Pharmaceuticals
6. Transcept Pharmaceuticals, Inc. to Present at UBS 2007 Global Life Sciences Conference
7. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Tapestry Pharmaceuticals, Inc.
8. Amylin Pharmaceuticals to Webcast Corporate Overview During 43rd Annual Meeting of the European Association for the Study of Diabetes
9. Major Pharma Clinical Case Studies From Amgen, AstraZeneca, GSK, Intermune, Cephalon Inc, Sunesis Pharmaceuticals and Dartmouth Medical School During Fall Clinical Focused Programs
10. Provectus Pharmaceuticals, Inc. releases summary results of phase 1 metastatic melanoma study
11. Class Settlement Could Result in Considerable Savings for Certain Consumers of Prescription Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2014)... Germany, September 2, 2014 In a large ... researchers found that mild cognitive impairment (MCI) occurred ... mellitus type 2. Interestingly, this strong association was ... in older participants (66-80 years) the association vanished. ... of Alzheimer,s Disease . , The concept of ...
(Date:9/2/2014)... Operators in the Community Services industry ... arranging care and counsel for those in need. In ... to derive $39.4 billion in revenue, which includes a ... the five years through 2014-15, the subdivision is forecast ... growth of 4.1% in 2014-15. , As the population ...
(Date:9/2/2014)... HealthDay Reporter TUESDAY, Sept. ... with weight loss by blocking a certain nerve linked to ... among obese patients. Using electric impulses to block the ... hoped to suppress feelings of hunger. And, they did, just ... safely blocks the nerve that connects the brain to the ...
(Date:9/2/2014)... LEBANON, NH Doctors trained in locations with less ... better at making clinical decisions that spare patients unnecessary ... in JAMA Internal Medicine . , "Growing concern ... spurred interest in assessing physicians, ability to avoid the ... of the VA Outcomes Group and The Dartmouth Institute ...
(Date:9/2/2014)... GA (PRWEB) September 02, 2014 Last year, ... new level with the launch of a luxurious line of ... announce that the SEA ISLAND COTTON Socks are joining the ... level, giving more people the comfort of natural cotton fibers. ... Socks, they are surprised to find socks as soft as ...
Breaking Medicine News(10 mins):Health News:Diabetes mellitus and mild cognitive impairment: Higher risk in middle age? 2Health News:Community Services in Australia Industry Market Research Report Now Updated by IBISWorld 2Health News:Community Services in Australia Industry Market Research Report Now Updated by IBISWorld 3Health News:Nerve Blocking Procedure Fails to Impress in Weight Loss Study 2Health News:Nerve Blocking Procedure Fails to Impress in Weight Loss Study 3Health News:Residency training predicts physicians' ability to practice conservatively 2Health News:SIGVARIS’ Luxury Line of Compression Socks, SEA ISLAND COTTON, Now Available in Stronger Compression Level 2
... tax plan to the nation, Congressional Democrats // all but ... of employer-based care and burden middle-class working families. ... the Midwest state of Missouri, said that changing private health ... more people. He added that his plan would move Americans ...
... to provide incentives to drug users on methadone for heroin ... way to encourage drug users to give up the habit, ... employed in the past, in the United States, have always ... given compensation, if their urine or blood sample proves abstinence ...
... a good health, it is necessary to have the right ... of the Pennington Biomedical Research Centre//, of Louisiana State University ... Ravussin and his team, who conducted a research on the ... selectively on the abdomen or on the thigh. Body metabolism ...
... silver dollar-sized region deep in the brain called the insula ... new research//. ,Obviously brain damage is not ... may offer leads for therapies to help smokers kick the ... say reports in latest issue of the journal Science., ...
... the stress experienced by a pregnant woman has a ... This was disclosed by Vivette Glover of Imperial College, ... this study, if the level of cortisol, the stress ... Attention Deficit Hyperactivity Disorders (ADHD) and a delayed cognitive ...
... to New York health officials, condoms would have more users ... of considering various options of casing the condoms. ... subway theme. A novel way of wrapping the condom could ... same by the people. , ,On an average, ...
Cached Medicine News:Health News:Democrats Balk at Bush's Health Insurance Proposal 2Health News:Democrats Balk at Bush's Health Insurance Proposal 3Health News:Democrats Balk at Bush's Health Insurance Proposal 4
(Date:9/2/2014)... -- According to the new market research ... by Material (Metal, Glass, Plastic), by Application [GC, LC ... published by MarketsandMarkets, the Chiral Chromatography Columns Market was ... grow at a CAGR of 5.2% from 2013 to ... 90 market data tables and 15 figures spread through ...
(Date:9/2/2014)... Sept. 2, 2014  Avanir Pharmaceuticals, Inc. (NASDAQ: ... overview of the company at the Morgan Stanley Global Healthcare ... , Presentation date: Tuesday September 9, 2014 , Presentation ... webcast and 30-day archive of this presentation will be available ... Inc. Avanir Pharmaceuticals, Inc. is a biopharmaceutical company ...
(Date:9/2/2014)... Mass. , Sept. 2, 2014  EMD Serono, ... Germany , announced today that Drew Young ... Neurology and Immunology. In this capacity, he will be ... Neurology and Immunology franchise, including future products.   ... and U.S. marketing and sales efforts at pharmaceutical and ...
Breaking Medicine Technology:Chiral Chromatography Column Market Worth $87.8 Million by 2018 2Chiral Chromatography Column Market Worth $87.8 Million by 2018 3Chiral Chromatography Column Market Worth $87.8 Million by 2018 4EMD Serono Appoints Drew Young to Senior Vice President, Neurology and Immunology 2EMD Serono Appoints Drew Young to Senior Vice President, Neurology and Immunology 3EMD Serono Appoints Drew Young to Senior Vice President, Neurology and Immunology 4
... Mobile Dog Heart Health Tour is heading south to ... health examinations in San Antonio,s McAllister Dog Park. From ... veterinary cardiologists will be performing on site heart screenings ... owners about canine heart disease. (Photo: ...
... Celsis In Vitro, Inc. (Celsis IVT) announced today ... District of Illinois in Chicago has entered a preliminary ... (the Defendants) due to their infringement of U.S. Patent ... California (Nasdaq: LIFE ) is the parent ...
Cached Medicine Technology:Free Dog Heart Checks at McAllister Park 2Free Dog Heart Checks at McAllister Park 3Celsis IVT Wins Preliminary Injunction Against Life Technologies and CellzDirect in Liverpool™ Patent Infringement Lawsuit 2Celsis IVT Wins Preliminary Injunction Against Life Technologies and CellzDirect in Liverpool™ Patent Infringement Lawsuit 3
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: